Advanced search×

Refractory breathlessness: oxygen or room air?

Irene J Higginson

Lancet 376(9743):746-8 (2010) PMID 20816528

Copyright © 2010 Elsevier Ltd. All rights reserved.

DOI: 10.1016/S0140-6736(10)61346-3
Version: za2963e q8za0 q8zb8 q8zc3 q8zdf q8ze0 q8zf2 q8zg5
Buy PDF

Similar articles you may find interesting…

  1. Prostate specific antigen for assessing response to ketoconazole and prednisone in patients with hormone refractory metastatic prostate canc...
    G S GS Gerber and G W GW Chodak

    J Urol 144(5):1177-9 (1990) PMID 1700145

    Serial prostate specific antigen levels were assessed in 15 patients with hormone refractory metastatic prostate cancer treated with ketoconazole and prednisone. Of the men 12 (80%) with continually increasing prostate specific antigen levels before treatment had a decrease in prostate specific anti...
    Buy PDF
  2. Does oncotype DX recurrence score affect the management of patients with early-stage breast cancer?
    Juhi J Asad, Allyson F AF Jacobson, ... Paul I PI Tartter

    Am J Surg 196(4):3 (2008) PMID 18809056

    Oncotype DX RS is significantly related to tumor grade and Her2/neu status. In this study, the treatment of 44% of patients was altered as a consequence of Oncotype DX RS....
    Buy PDF
  3. When genomic and standard test results diverge: implications for breast cancer patients' preference for chemotherapy.
    Noel T Brewer, Alrick S Edwards, ... Barbara K Rimer

    Breast Cancer Res Treat 117(1):25-9 (2009) PMID 18785002

    Some women may be reluctant to forgo chemotherapy when genomic tests indicate low recurrence risk but standard criteria suggest high risk. Additional research including replication of the findings of this small, vignette-based study is needed....
    Buy PDF